Neurorehabilitation & Neural Repair offers neurologists, neurosurgeons, physiatrists, rehabilitation nurses, discharge planners, social workers, basic scientists working in neural regeneration and plasticity, and physical, occupational, and speech therapists innovative and reliable reports relevant to functional recovery from neural injury and long term neurologic care. The journal's unique focus is evidence-based basic and clinical practice and research.
NNR deals with the management and fundamental mechanisms of functional recovery from conditions such as stroke, multiple sclerosis, cerebral palsy, Parkinson’s disease and other movement disorders, Alzheimer’s disease and dementia, traumatic and acquired brain injuries and related secondary conditions, spinal cord injuries, and peripheral nerve injuries.
Some of the key topics covered in recent issues include cortical remodeling after stroke, traumatic brain injury or spinal cord injury studied by transcranial magnetic stimulation and functional magnetic resonance imaging, mechanisms of sprouting and regeneration, development of cell lines for transplantation and trophic factor replacement strategies to promote functional recovery in human patients, multidisciplinary management of neurologic disease, bioengineering and assistive devices used in the management of neurologic impairment or pain syndromes, pharmacological management of multiple sclerosis, pharmacology of motor recovery, cognitive rehabilitation, and design of randomized multicenter trials in neurorehabilitation.
The journal carries articles designed to appeal to a variety of audiences: clinical practice, research, brief communications, case reports, reviews, and media reviews.
This journal is a member of the Committee on Publication Ethics (COPE).
The Journal will consider for publication original articles and reviews on both basic science and clinical research relevant to recovery from neural injury. Examples of appropriate topics include cortical remodeling, mechanisms of sprouting and regeneration, the development of cell lines for transplantation and trophic factor replacement, strategies to promote functional recovery in human patients, design of outcome measures in neurologic rehabilitation, the multidisciplinary management of neurologic disease, and bioengineering and assistive devices used in the management of neurologic impairment.
|Randolph J. Nudo, PhD||University of Kansas Medical Center|
|Gert Kwakkel, PT, PhD||VU University Medical Centre Amsterdam|
|Labe D. Scheinberg, MD||Founding Editor|
|Michael E. Selzer, MD||University of Pennsylvania, USA|
|Bruce H. Dobkin, MD||University of California, Los Angeles|
|S. Thomas Carmichael||University of California, Los Angeles, USA|
|Stephanie Clarke, MD||University of Lausanne|
|Leonardo Cohen, MD||National Institutes of Health|
|Ichiro Miyai, MD, PhD||Morinomiya Hospital|
|Louis Quatrano, PhD||National Institute of Health|
|Carol Richards, PhD||University of Laval|
|Nick Ward||University College London, Institute of Neurology|
|Steven Wolf||Emory University, USA|
|Phillipe Azouvi, MD, PhD||Hopital Raymond Poincare|
|Amy Bastian||Johns Hopkins School of Medicine|
|Barbara Bregman, PhD, PT||Georgetown University Medical Ctr.|
|Jane Burridge||University of Southampton, UK|
|Leanne Carey, OT, PhD||La Trobe University|
|Maurizio Corbetta, MD||Washington University|
|Steven Cramer, MD||University of California at Irvine|
|Diane Damiano, PhD, Pt||Washington University, USA|
|Bruce H. Dobkin, MD||University of California, Los Angeles|
|Arthur W. English, PhD||Emory University|
|Scott Frey, PhD||Washington University|
|David Johnson||City University London, UK|
|Douglas I. Katz||Boston University School of Medicine, Massachusetts|
|Mindy F. Levin, PhD, PT||McGill University|
|Leonard S.W. Li||Hong Kong University|
|John Martin, PhD||The City College of New York|
|Thomas A. Matyas, PhD||La Trobe University|
|Robert W. Motl, PhD||University of Illinois, Urbana-Champaign|
|Marion Murray, PhD||Drexel University School of Medicine, Philadelphia, PA|
|Alice Nieuwboer||Katholieke Universiteit Leuven, Belgium|
|John Rothwell, MD||Institute of Neurology, United Kingdom|
|Rudiger Seitz, MD||University Hospital Duesseldorf, Germany|
|Michael E. Selzer, MD||University of Pennsylvania, USA|
|Wolfram Tetzlaff, MD, PhD||The University of British Columbia, Canada|
|Valerie Pomeroy, PhD||University of East Anglia, UK|
|H.J.A. van Hedel, PT, PhD||University Children's Hospital Zurich|
|Carolee Winstein PhD, PT||University of Southern California, USA|
|Sam Wu, PhD||University of Florida|
Neurorehabilitation and Neural Repair will consider manuscripts that have not been published elsewhere, except in abstract form, on any clinical or basic science topic that is relevant to understanding and rehabilitating the consequences of neural injury and disease. Neurorehabilitation and Neural Repair especially promotes the translation of concepts from the basic sciences to clinical trials and the care of patients. Appropriate topics include, but are not limited to, randomized controlled clinical trials of interventions; well-designed pilot studies that include control subjects of physical, cognitive, language, neuropsychologic, pharmacologic, neurostimulation, and other potential approaches to augment procedural or declarative learning and function, and to lessen impairment and disability; fundamental mechanisms of motor, sensory, and cognitive improvements after injury or induced by rehabilitation strategies; neural reorganization, synaptogenesis, neurogenesis, and regeneration associated with gene expression after injury, biological interventions, and training paradigms; neurotransplantation with behavioral outcomes; neurophysiologic probes of activity-dependent plasticity during rehabilitation, such as functional magnetic resonance imaging and transcranial magnetic stimulation; epidemiologic and longitudinal studies of disability and rehabilitation; novel research designs, statistical procedures, and outcome measures for neurologic rehabilitation; multidisciplinary approaches to lessen disability and increase participation in persons with chronic neurologic disorders; and bioengineered, assistive, and robotic devices for training or for managing impairment and disability.
If a manuscript is not consistent with the scientific rigor or themes of interest to the journal, the editor may return the article without peer review. The associate editors and the editor make final decisions about acceptance or rejection based on their final review.
Expedited review and publication is possible for suitable manuscripts at the request of the author.
CONTRIBUTIONS VIA SAGETRACK: Manuscripts should be submitted electronically to http://mc.manuscriptcentral.com/nnr where authors will be required to set up an online account on the SAGETRACK system powered by ScholarOne.
All accepted manuscripts will be subject to copyediting. Please have English language usage checked.
Neurorehabilitation & Neural Repair does not mask the names and affiliations of the authors from reviewers.
PLEASE READ THE FOLLOWING TO CONFORM TO NNR REQUIREMENTS
Submissions that will be considered include:
Full-length original research articles should have an Abstract, Introduction, Methods, Results, and Discussion. The word count of the text must not exceed 4,000. Tables and figures combined should not exceed six (6). References should not exceed 60.
Review articles should have an Abstract, but the organization of the body of text is flexible. The text should not exceed 4,000 words and 75 references.
Point of View: Directions for Research articles offer an opportunity for clinical and basic researchers to examine controversies in the conceptualization of a particular research problem, in a methodology, or in the interpretation of past results that continue to influence the neurorehabilitation literature. Specific suggestions must be made and justified about how to better conduct research around that particular issue. The aim is to improve the ability of clinicians to interpret the literature, translate research studies into practices, and better direct future experiments. One format would be Introduction, The Problem, The Solution, and Recommendations for strategies to try to resolve the controversy. Include an abstract. The text should not exceed 4,500 words and 75 references.
Brief communications and case reports should be labeled as such and must offer an important new observation and not simply review the literature. Theses reports must contain no more than 1000 words, 10 references, and 2 figures or tables. They should include an abstract, but subdivision into Introduction, Methods, Results, and Discussion is optional.
Images in neurorehabilitation: We will consider photographic, radiographic, or artistic images that have exceptional visual impact and have relevance to neurologic rehabilitation. These images should make up a single figure, although they may contain more than one frame. Accompanying text must be 1 page or less of double-spaced type.
COVER LETTER: A cover letter must accompany the manuscript explaining any duplication or overlap in content with a previously published article, or stating, "No part of this work has been published." The letter should identify any commercial interest of the authors relevant to the subject of the manuscript, or state that no such conflict of interest exists. All authors must sign off on the submission. State the type of article based on the above information.
NNR FORMAT STYLE FOR MANUSCRIPTS
All submissions should be in English in 12-point Arial, Times, or Times New Roman font. Double-space the text with a 2.5 cm (1 inch) left margin and do not justify the right margin. Do not include tracked changes or line numbers in the final submitted manuscript. The beginning of each new paragraph should be indented. (Instructions for resubmissions are provided below.)
Refer to patients by number. Real names or initials should not be used in the text, tables, or illustrations. The title page should include
1. the title of the article;
2. the names, highest degrees, and full affiliations of all authors;
3. the name, mailing address, email address, and telephone number of the corresponding author to whom proofs and reprint requests should be addressed;
4. word count of the text and the number of figures and tables in the article; and
5. a running title that should not exceed 42 letters and spaces in the upper right corner.
An important goal of Neurorehabilitation and Neural Repair is to foster communication between the basic and clinical research communities whose work is relevant to recovery from neural injury. Therefore, basic science articles should include sufficient explanatory information in the Introduction and elsewhere to permit reading by clinicians, and vice versa. All abbreviations and jargon terms should be defined and kept to a minimum. Other than very common measurement tools, such as the Fugl-Meyer Assessment (F-M), do not use more than 4 abbreviations for names and phrases in the text. Most non-experts cannot hold more than 4 unfamiliar terms in mind over the course of an article.
Headings in the text should appear as follows in bold and italics: Introduction; Methods, then Subheadings for Each Section; Results, then Subheadings for Each Section; Discussion then Subheadings; Conclusions/Implications (if not repeating what has been stated).
Organization of text:
Abstract: Abstracts may contain up to 250 words and structured with the following subheadings: Background, Objective, Methods, Results, Conclusions. Do not simply repeat the Results in the Conclusions – state what was learned and what needs to be done next.
Key Words: Up to 6 key words or terms from MeSH terms in PubMed should be included for use by referencing sources. If you wish to have your paper cited, choose the best terms.
The Introduction should briefly explain why you have undertaken the study/review. Explain how the study addresses an important problem. What is novel, what is incremental? State your objectives and the hypotheses that are to be tested. Use only the most critical and best studies as references.
The Methods should define the participants, how and why they were chosen, the tools you used, and their reliability and validity for your population, and how you examined your hypotheses. Include how the sample size was determined and how randomization was performed, when applicable. State your primary and secondary outcome measurements and why you chose these. Explain how blinding was carried out, when applicable. Justify your statistical methods for primary and secondary analyses. When relevant, the Methods must include a statement that the project was approved by an authorized institutional human research review board or institutional animal research authority.
The Results should include recruitment, baseline data, the number of participants that were in each analysis, the pre-specified statistical comparisons between groups before the analyses of pre- vs post-test results within groups, corrections for multiple comparisons, and adverse events.
All randomized clinical trials must be listed in clinical trials.gov. All randomized clinical trials must include a CONSORT flow diagram of subject progress through the phases of the trial, as well as meet the CONSORT checklist of items to be included when reporting a randomized trial.
See Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. BMJ. 2010 Mar 23;340:c332. doi: 10.1136/bmj.c332.
A Chinese version is found in Zhong Xi Yi Jie He Xue Bao. 2010 Jul;8(7):604-12. Chinese. PubMed PMID: 20619135.
The Discussion should interpret the Results, including adjusted analyses, within the hypotheses and potential biases and confounders of the Methods. What is the generalizability of the data? The rationale and significance of the reported research should be explained in terms of its relevance to recovery of neurologic function. Implications or Conclusions may be added. Latitude to briefly consider the clinical implications of basic research findings is permitted here. Clinical researchers may use this section to suggest what clinical and basic science advances are needed to move the clinical research forward toward value for patients.
Acknowledgments: Acknowledgments should be made at the end of the text. List the agency and number for grant support. Limit personal acknowledgments. Disclosure of any commercial interest of the authors relevant to the subject of the manuscript should follow.
Conflict of Interest: You must fill out and attach the ICJME Conflict of Interest form with your manuscript files. Download and form instructions are available at their web site: http://www.icmje.org/coi_instructions.html.
Conflict of Interest form that can be downloaded.
Tables: All tables must have a title, be self-explanatory, and supplement (not duplicate) the text. All abbreviations should be defined. Tables should be placed at the end of the file, following text and references, with callouts for each in the text. Elements in tables should be separated by tabs, not cells or lines.
Figures: High-resolution figures must be uploaded as separate electronic files, with callouts for each in the text. Each figure must be labeled, include a short title, and brief legend. All abbreviations should be defined. Acceptable file formats for figures include TIFF, EPS, and JPEG, and PDF Microsoft Application Files are acceptable for vector art (line art). Figures must be at least 300 dpi for good print quality. This will permit minor revisions to be made in press without the need for authors to remake figures.
Color illustrations will be charged to authors at $800 per page (more than one set of figures may fit on a page). If you do not wish to pay for color, the print version will be in B&W, but you can request the on-line version to include color. Please indicate this upon your submission.
Drug names: Use generic names only in referring to drugs, followed in parentheses after first mention by any commonly used variant generic or brand names.
Abbreviations: Follow the American Medical Association Manual of Style (AMA). For abbreviations of journal names, refer to List of Journals Indexed in Index Medicus.
References: The reference style of the journal is the American Medical Association Manual of Style. Cite references in the text by number, and number them in the order in which they are cited. Type the reference section double-spaced at the end of the text, following the examples given below. For each reference, provide all authors’ names when fewer than 7; when 7 or more, list the first 3 and add et al. Be sure to provide the title of each article and inclusive pages. Do not include the month or issue number. Accuracy of reference data is the responsibility of the author.
1. Winstein C, Miller J, Blanton S, et al. Methods for a multi-site randomized trial to investigate the effect of constraint-induced movement therapy in improving upper extremity function among adults recovering from a cerebrovascular stroke. Neurorehabil Neural Repair 2003;17:137-52.
2. Dobkin BH. The clinical science of neurologic rehabilitation. New York, NY: Oxford University Press; 2003.
Chapter in Book:
3. Chollet F. Plasticity of the adult human brain. In: Toga AW, Mazziotta JC, eds. Brain mapping: the systems. San Diego, CA: Academic Press; 2000:621-636.
PHOTOGRAPHIC CONSENTS: A letter of consent must accompany all photographs of patients in which the possibility of identification exists. It is not sufficient to cover the eyes to mask identity.
RESUBMISSIONS: Resubmissions must include 1) a clean copy of the revised manuscript, 2) a copy of the revised manuscript with the changes highlighted, and 3) a point-by-point response to reviewers. Each should be uploaded as separate Word documents.
PROOFS: Proofs must be returned by the deadline specified; late return may cause a delay in publication of an article. Please check text, tables, legends, and references carefully. To expedite publication, authors will receive page proofs rather than galley proofs for review; it is therefore essential that corrections be kept to an absolute minimum. Changes or additions in page proofs that exceed 10% of the article length will be charged to the author.
REPRINTS: An order form for reprints will be included with proofs. Mail proof and reprint order form to Customer Care Department, Sage Publications, 2455 Teller Road, Thousand Oaks, CA 91320. Phone: (800) 818-7243; Fax: (805) 499-0871. E-mail: email@example.com.
COPYRIGHT: Copyright on all published articles will be held by The American Society of Neurorehabilitation. To comply with United States copyright law, a copyright transfer form will be sent to the corresponding author when a manuscript is accepted for publication--the corresponding author is authorized to sign on behalf of all authors. Please only submit one copyright form signed by the corresponding author.
PubMed: We have received inquiries from journal authors about our policy regarding NIH compliance, which mandates that the final, peer-reviewed manuscripts, upon acceptance for publication, be made publicly available no later than 12 months after the official date of publication. The NIH policy meets our own posting policy at the first anniversary of the date of the NIH-funded article’s publication. As stated on the recently revised contributor agreement, our policy is as follows:
“No sooner than twelve (12) months after publication of the Contribution in the print edition of the Journal, the Contributor-created version of all or part of the Contribution and abstract as accepted for publication by the Journal (i.e., updated to include all changes made during the peer-review and editing process) may be posted on any non-commercial Web site or repository, provided that such electronic copy includes a hyperlink to the published version of the Contribution on the SAGE Journals Online Web site, together with the following text: ‘The final, definitive version of the article is available at http://online.sagepub.com/.’ Contributor is not permitted to post the SAGE PDF version of the published Contribution on any Web site or repository.”
Authors are free to provide their own author-created copies of the peer-reviewed version of the article to PubMedCentral and other public repositories with the understanding that the article will not be made available until 12 months after publication. The PubMed FAQ site has information on the policy and on how to submit: http://www.nihms.nih.gov/help/faq.shtml.